SGLT-2抑制-话题@MedSci

#SGLT-2抑制#

28篇内容 | 565人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1793926, encodeId=7a9e1e939267b, content=<a href='/topic/show?id=722516221ec' target=_blank style='color:#2F92EE;'>#SGLT-2抑制#</a>, objectTitle=Cardiovasc Diabetol：GLP-1受体激动剂与SGLT-2抑制剂在2型糖尿病的有效性和安全性, objectType=article, longId=739436, objectId=f1a5e39436f8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f1a5e39436f8, replyNumber=0, likeNumber=50, createdTime=2023-04-17, rootId=0, userName=yyj062, userId=052a130, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f1a5e39436f8, moduleTitle=Cardiovasc Diabetol：GLP-1受体激动剂与SGLT-2抑制剂在2型糖尿病的有效性和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f1a5e39436f8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1793924, encodeId=57581e9392435, content=<a href='/topic/show?id=722516221ec' target=_blank style='color:#2F92EE;'>#SGLT-2抑制#</a>, objectTitle=磺脲类药物治疗2型糖尿病时若需添加SGLT-2抑制剂，可适当减少剂量以降低“低血糖”风险, objectType=article, longId=737027, objectId=7b6ee370276e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7b6ee370276e, replyNumber=0, likeNumber=50, createdTime=2022-12-12, rootId=0, userName=yyj062, userId=052a130, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7b6ee370276e, moduleTitle=磺脲类药物治疗2型糖尿病时若需添加SGLT-2抑制剂，可适当减少剂量以降低“低血糖”风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7b6ee370276e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1793923, encodeId=a07f1e939230d, content=<a href='/topic/show?id=722516221ec' target=_blank style='color:#2F92EE;'>#SGLT-2抑制#</a>, objectTitle=Cardiovasc Diabetol：DPP-4抑制剂、GLP-1受体激动剂和SGLT-2抑制剂对心肾结局的影响, objectType=article, longId=723796, objectId=c62be2379617, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c62be2379617, replyNumber=0, likeNumber=42, createdTime=2022-05-16, rootId=0, userName=yyj062, userId=052a130, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c62be2379617, moduleTitle=Cardiovasc Diabetol：DPP-4抑制剂、GLP-1受体激动剂和SGLT-2抑制剂对心肾结局的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c62be2379617)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1793922, encodeId=95571e93922d2, content=<a href='/topic/show?id=722516221ec' target=_blank style='color:#2F92EE;'>#SGLT-2抑制#</a>, objectTitle=ACC/AHA/HFSA 2022：推荐SGLT-2抑制剂用于治疗心衰, objectType=article, longId=723398, objectId=d22be233981c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d22be233981c, replyNumber=0, likeNumber=37, createdTime=2022-05-04, rootId=0, userName=yyj062, userId=052a130, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d22be233981c, moduleTitle=ACC/AHA/HFSA 2022：推荐SGLT-2抑制剂用于治疗心衰, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d22be233981c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1793921, encodeId=73001e9392154, content=<a href='/topic/show?id=722516221ec' target=_blank style='color:#2F92EE;'>#SGLT-2抑制#</a>, objectTitle=Cardiovasc Diabetol：GLP-1激动剂 vs SGLT-2抑制剂 vs DPP-4抑制剂对T2DM患者心肾结局的影响, objectType=article, longId=301367, objectId=c4b830136e91, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c4b830136e91, replyNumber=0, likeNumber=34, createdTime=2023-01-10, rootId=0, userName=yyj062, userId=052a130, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c4b830136e91, moduleTitle=Cardiovasc Diabetol：GLP-1激动剂 vs SGLT-2抑制剂 vs DPP-4抑制剂对T2DM患者心肾结局的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c4b830136e91)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1793925, encodeId=53811e9392543, content=<a href='/topic/show?id=722516221ec' target=_blank style='color:#2F92EE;'>#SGLT-2抑制#</a>, objectTitle=重磅！SGLT-2抑制剂「恩格列净」在华获批，用于治疗射血分数保留的成人心力衰竭, objectType=article, longId=737405, objectId=2c50e37405f8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2c50e37405f8, replyNumber=0, likeNumber=36, createdTime=2023-06-28, rootId=0, userName=yyj062, userId=052a130, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2c50e37405f8, moduleTitle=重磅！SGLT-2抑制剂「恩格列净」在华获批，用于治疗射血分数保留的成人心力衰竭, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2c50e37405f8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1793920, encodeId=e6791e9392083, content=<a href='/topic/show?id=722516221ec' target=_blank style='color:#2F92EE;'>#SGLT-2抑制#</a>, objectTitle=BMJ子刊：SGLT-2抑制剂会造成肾损伤吗？这项2万多人的队列研究告诉你答案！, objectType=article, longId=292226, objectId=5d56292226bc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5d56292226bc, replyNumber=0, likeNumber=85, createdTime=2022-11-29, rootId=0, userName=yyj062, userId=052a130, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5d56292226bc, moduleTitle=BMJ子刊：SGLT-2抑制剂会造成肾损伤吗？这项2万多人的队列研究告诉你答案！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5d56292226bc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1793915, encodeId=dd4d1e939151c, content=<a href='/topic/show?id=722516221ec' target=_blank style='color:#2F92EE;'>#SGLT-2抑制#</a>, objectTitle=JAMA Intern Med：SGLT-2抑制剂 vs磺脲类药物对II型糖尿病患者死亡风险的影响, objectType=article, longId=213849, objectId=4ba12138498f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4ba12138498f, replyNumber=0, likeNumber=30, createdTime=2022-05-17, rootId=0, userName=yyj062, userId=052a130, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4ba12138498f, moduleTitle=JAMA Intern Med：SGLT-2抑制剂 vs磺脲类药物对II型糖尿病患者死亡风险的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4ba12138498f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1793917, encodeId=18191e93917af, content=<a href='/topic/show?id=722516221ec' target=_blank style='color:#2F92EE;'>#SGLT-2抑制#</a>, objectTitle=Diabetes Obes Metab：SGLT-2抑制剂对T2DM患者血清尿酸水平的影响, objectType=article, longId=218712, objectId=149f218e125c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=149f218e125c, replyNumber=0, likeNumber=32, createdTime=2021-12-03, rootId=0, userName=yyj062, userId=052a130, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=149f218e125c, moduleTitle=Diabetes Obes Metab：SGLT-2抑制剂对T2DM患者血清尿酸水平的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=149f218e125c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1793918, encodeId=0d4b1e9391815, content=<a href='/topic/show?id=722516221ec' target=_blank style='color:#2F92EE;'>#SGLT-2抑制#</a>, objectTitle=Drugs：SGLT-2抑制剂在治疗非糖尿病性慢性肾病中的作用, objectType=article, longId=219863, objectId=fc9021986320, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fc9021986320, replyNumber=0, likeNumber=28, createdTime=2021-12-27, rootId=0, userName=yyj062, userId=052a130, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fc9021986320, moduleTitle=Drugs：SGLT-2抑制剂在治疗非糖尿病性慢性肾病中的作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fc9021986320)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1793919, encodeId=da951e939197c, content=<a href='/topic/show?id=722516221ec' target=_blank style='color:#2F92EE;'>#SGLT-2抑制#</a>, objectTitle=Diabetes Obes Metab：肾血流动力学对SGLT-2抑制剂的反应不依赖于蛋白质摄入量, objectType=article, longId=219913, objectId=119c21991317, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=119c21991317, replyNumber=0, likeNumber=25, createdTime=2022-05-16, rootId=0, userName=yyj062, userId=052a130, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=119c21991317, moduleTitle=Diabetes Obes Metab：肾血流动力学对SGLT-2抑制剂的反应不依赖于蛋白质摄入量, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=119c21991317)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1793916, encodeId=793b1e939162b, content=<a href='/topic/show?id=722516221ec' target=_blank style='color:#2F92EE;'>#SGLT-2抑制#</a>, objectTitle=降糖药SGLT-2抑制剂也能治心衰？看完本文马上掌握！, objectType=article, longId=214626, objectId=4e1d214626dd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4e1d214626dd, replyNumber=0, likeNumber=35, createdTime=2021-10-26, rootId=0, userName=yyj062, userId=052a130, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4e1d214626dd, moduleTitle=降糖药SGLT-2抑制剂也能治心衰？看完本文马上掌握！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4e1d214626dd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1793914, encodeId=93981e9391494, content=<a href='/topic/show?id=722516221ec' target=_blank style='color:#2F92EE;'>#SGLT-2抑制#</a>, objectTitle=BMJ：SGLT-2抑制剂或GLP-1受体激动剂治疗糖尿病的临床优势, objectType=article, longId=205766, objectId=c84a205e66fd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c84a205e66fd, replyNumber=0, likeNumber=53, createdTime=2021-11-14, rootId=0, userName=yyj062, userId=052a130, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c84a205e66fd, moduleTitle=BMJ：SGLT-2抑制剂或GLP-1受体激动剂治疗糖尿病的临床优势, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c84a205e66fd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1793913, encodeId=77311e9391301, content=<a href='/topic/show?id=722516221ec' target=_blank style='color:#2F92EE;'>#SGLT-2抑制#</a>, objectTitle=2019 日本建议：正确使用SGLT-2抑制剂, objectType=article, longId=184705, objectId=d6e2184e05d3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d6e2184e05d3, replyNumber=0, likeNumber=31, createdTime=2020-01-01, rootId=0, userName=yyj062, userId=052a130, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d6e2184e05d3, moduleTitle=2019 日本建议：正确使用SGLT-2抑制剂, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d6e2184e05d3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1793912, encodeId=0af81e9391217, content=<a href='/topic/show?id=722516221ec' target=_blank style='color:#2F92EE;'>#SGLT-2抑制#</a>, objectTitle=JAMA Intern Med：SGLT-2抑制剂增加2型糖尿病患者截肢风险？, objectType=article, longId=149241, objectId=d458149241bb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d458149241bb, replyNumber=0, likeNumber=38, createdTime=2019-06-28, rootId=0, userName=yyj062, userId=052a130, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d458149241bb, moduleTitle=JAMA Intern Med：SGLT-2抑制剂增加2型糖尿病患者截肢风险？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d458149241bb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1793911, encodeId=cd791e9391117, content=<a href='/topic/show?id=722516221ec' target=_blank style='color:#2F92EE;'>#SGLT-2抑制#</a>, objectTitle=JAMA Intern Med：SGLT-2抑制剂增加糖尿病患者下肢截肢风险, objectType=article, longId=146618, objectId=28f4146618a8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=28f4146618a8, replyNumber=0, likeNumber=49, createdTime=2019-03-03, rootId=0, userName=yyj062, userId=052a130, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=28f4146618a8, moduleTitle=JAMA Intern Med：SGLT-2抑制剂增加糖尿病患者下肢截肢风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=28f4146618a8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1793908, encodeId=a7b21e9390874, content=<a href='/topic/show?id=722516221ec' target=_blank style='color:#2F92EE;'>#SGLT-2抑制#</a>, objectTitle=Diabetes Obes Metab：SGLT-2抑制剂后来者居上长期疗效完胜DPP-4i和磺脲类, objectType=article, longId=139721, objectId=9b09139e213c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9b09139e213c, replyNumber=0, likeNumber=46, createdTime=2018-07-04, rootId=0, userName=yyj062, userId=052a130, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9b09139e213c, moduleTitle=Diabetes Obes Metab：SGLT-2抑制剂后来者居上长期疗效完胜DPP-4i和磺脲类, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9b09139e213c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1793910, encodeId=22161e939109a, content=<a href='/topic/show?id=722516221ec' target=_blank style='color:#2F92EE;'>#SGLT-2抑制#</a>, objectTitle=JACC：SGLT-2抑制剂可否降低2型糖尿病患者的心血管事件风险？, objectType=article, longId=144604, objectId=dfa914460422, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dfa914460422, replyNumber=0, likeNumber=31, createdTime=2019-03-11, rootId=0, userName=yyj062, userId=052a130, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dfa914460422, moduleTitle=JACC：SGLT-2抑制剂可否降低2型糖尿病患者的心血管事件风险？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dfa914460422)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1793907, encodeId=6bce1e93907ef, content=<a href='/topic/show?id=722516221ec' target=_blank style='color:#2F92EE;'>#SGLT-2抑制#</a>, objectTitle=Diabetes Obes Metab：T2DM患者进行DPP-4抑制与SGLT-2抑制对胰高血糖素的影响！, objectType=article, longId=131332, objectId=476e131332d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=476e131332d6, replyNumber=0, likeNumber=37, createdTime=2018-07-27, rootId=0, userName=yyj062, userId=052a130, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=476e131332d6, moduleTitle=Diabetes Obes Metab：T2DM患者进行DPP-4抑制与SGLT-2抑制对胰高血糖素的影响！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=476e131332d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1793909, encodeId=ede61e9390947, content=<a href='/topic/show?id=722516221ec' target=_blank style='color:#2F92EE;'>#SGLT-2抑制#</a>, objectTitle=ESH2018丨SGLT-2抑制剂对于合并糖尿病的高血压患者之影响, objectType=article, longId=140961, objectId=878d1409614b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=878d1409614b, replyNumber=0, likeNumber=42, createdTime=2018-06-26, rootId=0, userName=yyj062, userId=052a130, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=878d1409614b, moduleTitle=ESH2018丨SGLT-2抑制剂对于合并糖尿病的高血压患者之影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=878d1409614b)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

SGLT-2抑制

2020-05-29

yyj062 (审核中...)

前往app查看评论内容

#SGLT-2抑制#

Cardiovasc Diabetol：GLP-1受体激动剂与SGLT-2抑制剂在2型糖尿病的有效性和安全性

2023-04-17

yyj062 (审核中...)

前往app查看评论内容

#SGLT-2抑制#

磺脲类药物治疗2型糖尿病时若需添加SGLT-2抑制剂，可适当减少剂量以降低“低血糖”风险

2022-12-12

yyj062 (审核中...)

前往app查看评论内容

#SGLT-2抑制#

Cardiovasc Diabetol：DPP-4抑制剂、GLP-1受体激动剂和SGLT-2抑制剂对心肾结局的影响

2022-05-16

yyj062 (审核中...)

前往app查看评论内容

#SGLT-2抑制#

ACC/AHA/HFSA 2022：推荐SGLT-2抑制剂用于治疗心衰

2022-05-04

yyj062 (审核中...)

前往app查看评论内容

#SGLT-2抑制#

Cardiovasc Diabetol：GLP-1激动剂 vs SGLT-2抑制剂 vs DPP-4抑制剂对T2DM患者心肾结局的影响

2023-01-10

yyj062 (审核中...)

前往app查看评论内容

#SGLT-2抑制#

重磅！SGLT-2抑制剂「恩格列净」在华获批，用于治疗射血分数保留的成人心力衰竭

2023-06-28

yyj062 (审核中...)

前往app查看评论内容

#SGLT-2抑制#

BMJ子刊：SGLT-2抑制剂会造成肾损伤吗？这项2万多人的队列研究告诉你答案！

2022-11-29

yyj062 (审核中...)

前往app查看评论内容

#SGLT-2抑制#

JAMA Intern Med：SGLT-2抑制剂 vs磺脲类药物对II型糖尿病患者死亡风险的影响

2022-05-17

yyj062 (审核中...)

前往app查看评论内容

#SGLT-2抑制#

Diabetes Obes Metab：SGLT-2抑制剂对T2DM患者血清尿酸水平的影响

2021-12-03

yyj062 (审核中...)

前往app查看评论内容

#SGLT-2抑制#

Drugs：SGLT-2抑制剂在治疗非糖尿病性慢性肾病中的作用

2021-12-27

yyj062 (审核中...)

前往app查看评论内容

#SGLT-2抑制#

Diabetes Obes Metab：肾血流动力学对SGLT-2抑制剂的反应不依赖于蛋白质摄入量

2022-05-16

yyj062 (审核中...)

前往app查看评论内容

#SGLT-2抑制#

降糖药SGLT-2抑制剂也能治心衰？看完本文马上掌握！

2021-10-26

yyj062 (审核中...)

前往app查看评论内容

#SGLT-2抑制#

BMJ：SGLT-2抑制剂或GLP-1受体激动剂治疗糖尿病的临床优势

2021-11-14

yyj062 (审核中...)

前往app查看评论内容

#SGLT-2抑制#

2019 日本建议：正确使用SGLT-2抑制剂

2020-01-01

yyj062 (审核中...)

前往app查看评论内容

#SGLT-2抑制#

JAMA Intern Med：SGLT-2抑制剂增加2型糖尿病患者截肢风险？

2019-06-28

yyj062 (审核中...)

前往app查看评论内容

#SGLT-2抑制#

JAMA Intern Med：SGLT-2抑制剂增加糖尿病患者下肢截肢风险

2019-03-03

yyj062 (审核中...)

前往app查看评论内容

#SGLT-2抑制#

Diabetes Obes Metab：SGLT-2抑制剂后来者居上长期疗效完胜DPP-4i和磺脲类

2018-07-04

yyj062 (审核中...)

前往app查看评论内容

#SGLT-2抑制#

JACC：SGLT-2抑制剂可否降低2型糖尿病患者的心血管事件风险？

2019-03-11

yyj062 (审核中...)

前往app查看评论内容

#SGLT-2抑制#

Diabetes Obes Metab：T2DM患者进行DPP-4抑制与SGLT-2抑制对胰高血糖素的影响！

2018-07-27

yyj062 (审核中...)

前往app查看评论内容

#SGLT-2抑制#

ESH2018丨SGLT-2抑制剂对于合并糖尿病的高血压患者之影响

2018-06-26

科室
- - 订阅+
  - 更多科室
工具
服务